These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 36096364)
21. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study. Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y Front Immunol; 2022; 13():922195. PubMed ID: 35935989 [TBL] [Abstract][Full Text] [Related]
22. Injectable catechin-based supramolecular hydrogel for highly efficient application in HPV-associated OSCC. Lei S; Hu X; Song S; Zhang Y; Zhao H; Xu X; Dan H J Mater Chem B; 2023 Feb; 11(6):1191-1202. PubMed ID: 36537109 [TBL] [Abstract][Full Text] [Related]
23. PEGylated doxorubicin nanoparticles mediated by HN-1 peptide for targeted treatment of oral squamous cell carcinoma. Wang Y; Wan G; Li Z; Shi S; Chen B; Li C; Zhang L; Wang Y Int J Pharm; 2017 Jun; 525(1):21-31. PubMed ID: 28412450 [TBL] [Abstract][Full Text] [Related]
24. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma. Hsu PY; Chen JL; Kuo SL; Wang WL; Jan FW; Yang SH; Yang CY Integr Cancer Ther; 2022; 21():15347354221134921. PubMed ID: 36404765 [TBL] [Abstract][Full Text] [Related]
25. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238 [TBL] [Abstract][Full Text] [Related]
26. ICG/l-Arginine Encapsulated PLGA Nanoparticle-Thermosensitive Hydrogel Hybrid Delivery System for Cascade Cancer Photodynamic-NO Therapy with Promoted Collagen Depletion in Tumor Tissues. Sun Z; Wang X; Liu J; Wang Z; Wang W; Kong D; Leng X Mol Pharm; 2021 Mar; 18(3):928-939. PubMed ID: 33427470 [TBL] [Abstract][Full Text] [Related]
27. An injectable thermosensitive hydrogel loaded with an ancient natural drug colchicine for myocardial repair after infarction. Chen Y; Shi J; Zhang Y; Miao J; Zhao Z; Jin X; Liu L; Yu L; Shen C; Ding J J Mater Chem B; 2020 Feb; 8(5):980-992. PubMed ID: 31930242 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma. Yang SC; Wang WY; Zhou JJ; Wu L; Zhang MJ; Yang QC; Deng WW; Sun ZJ Int Immunopharmacol; 2022 Oct; 111():109113. PubMed ID: 35944462 [TBL] [Abstract][Full Text] [Related]
29. Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis. Zi M; Xingyu C; Yang C; Xiaodong S; Shixian L; Shicheng W Apoptosis; 2023 Apr; 28(3-4):348-361. PubMed ID: 36370260 [TBL] [Abstract][Full Text] [Related]
30. Near-infrared-II Ag Xiong H; Shao S; Yang Y; Wang W; Xiong H; Han Y; Wang Z; Hu X; Zeng L; Yang Z; Su T Biomed Pharmacother; 2024 Jan; 170():116011. PubMed ID: 38157644 [TBL] [Abstract][Full Text] [Related]
31. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling. Lu M; Wang C; Chen W; Mao C; Wang J DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705 [TBL] [Abstract][Full Text] [Related]
32. Single-Cell Profiling Reveals Heterogeneity of Primary and Lymph Node Metastatic Tumors and Immune Cell Populations and Discovers Important Prognostic Significance of CCDC43 in Oral Squamous Cell Carcinoma. Wang Z; Zhang H; Zhai Y; Li F; Shi X; Ying M Front Immunol; 2022; 13():843322. PubMed ID: 35401551 [TBL] [Abstract][Full Text] [Related]
33. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India. Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608 [TBL] [Abstract][Full Text] [Related]
34. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance. Wang S; Yang Y; Wang Y; Chen M Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923 [TBL] [Abstract][Full Text] [Related]
35. Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy. Lee YM; Hsu CL; Chen YH; Ou DL; Hsu C; Tan CT Cancer Immunol Res; 2023 Nov; 11(11):1553-1567. PubMed ID: 37669022 [TBL] [Abstract][Full Text] [Related]
36. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors. Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033 [TBL] [Abstract][Full Text] [Related]
37. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression. Prgomet Z; Axelsson L; Lindberg P; Andersson T J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554 [TBL] [Abstract][Full Text] [Related]
38. Overcoming chemotherapy resistance using pH-sensitive hollow MnO Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370 [TBL] [Abstract][Full Text] [Related]
39. Tumor microenvironment-activatable nanocatalysts with chemodynamic therapy and enhanced autophagy for specific treatment of oral squamous cell carcinoma. Xu H; Zheng C; Zhang Z; Huang X Colloids Surf B Biointerfaces; 2024 Apr; 236():113713. PubMed ID: 38422665 [TBL] [Abstract][Full Text] [Related]
40. Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy. Lym JS; Nguyen QV; Ahn da W; Huynh CT; Jae HJ; Kim YI; Lee DS Acta Biomater; 2016 Sep; 41():253-63. PubMed ID: 27184404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]